Ingmar N. Bastian

Ingmar N. Bastian

Auto-generated profile, based on publicly available information

Ingmar N. Bastian

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA; Department of Dermatology, University of California San Francisco, San Francisco, CA 94115, USA; Department of Pathology, University of California San Francisco, San Francisco, CA 94115, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2017 in Nature
Verified
Journal Article
Open access
PDF file
SSShabnam Shalapour
Shabnam Shalapour
XLXue-Jia Lin
Xue-Jia Lin
IBIngmar N. Bastian
Ingmar N. Bastian
JBJohn Brain
John Brain
ABAlastair D. Burt
Alastair D. Burt
MKMichael Karin
Michael Karin
IgA+ B cells expressing programmed death ligand 1 (PD-L1) and interleukin 10 accumulate in the inflamed livers of humans and mice with non-alcoholic fatty liver disease where they promote the progression to hepatocellular carcinoma by limiting the local activation of PD-1-expressing CD8+ T cells. The role of adaptive immunity in early cancer development is controversial. Here we show that chronic inflammation and fibrosis in humans and mice with non-alcoholic fatty liver disease is accompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA+) cells. These cells also express programmed death ligand 1 (PD-L1) and interleukin-10, and directly suppress liver cytotoxic CD8+ T lymphocytes, which prevent emergence of hepatocellular carcinoma and express a limited repertoire of T-cell receptors against tumour-associated antigens. Whereas CD8+ T-cell ablation accelerates hepatocellular carcinoma, genetic or pharmacological interference with IgA+ cell generation attenuates liver carcinogenesis and induces cytotoxic T-lymphocyte-mediated regression of established hepatocellular carcinoma. These findings establish the importance of inflammation-induced suppression of cytotoxic CD8+ T-lymphocyte activation as a tumour-promoting mechanism. Cancer progression beyond the early stages is thought to be caused in some cases by adaptive immunity, but its role remains controversial. In this study, Michael Karin and colleagues show that PD-L1-expressing IgA+ B cells accumulate in the inflamed livers of humans and mice with non-alcoholic fatty liver disease. The inflammation-induced IgA+ cells promote the progression to hepatocellular carcinoma by suppressing liver cytotoxic CD8+ T cells that prevent the emergence of this aggressive tumour.

1 July 2018 in Cancer Cell
Verified
Journal Article
Closed access
HZHanlin Zeng
Hanlin Zeng
AJAparna Jorapur
Aparna Jorapur
ASA. Hunter Shain
A. Hunter Shain
ULUrsula E. Lang
Ursula E. Lang
RTRodrigo Torres
Rodrigo Torres
RJRobert Judson-Torres
Robert Judson-Torres

1 April 2018
Verified
Journal Article
Closed access
ABAjaz Bulbul
Ajaz Bulbul
PFPatrick M. Forde
Patrick M. Forde
AMAyesha Murtuza
Ayesha Murtuza
BWBrian Woodward
Brian Woodward
HYHannah Yang
Hannah Yang
HHHatim Husain
Hatim Husain